Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CMPX · NASDAQ · Biological Products, (No Diagnostic Substances)
$0.6067−0.0548 (−8.28%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
Compass Therapeutics (CMPX) · oqro.io/stocks/CMPX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 17, 2026 · Filed Nov 18, 2026
Officer purchased ~$5.9K of CMPX shares in the open marketSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 2, 2026
Officer purchased ~$18K of CMPX shares in the open marketSourceInsider trade · Traded Sep 24, 2026 · Filed Sep 25, 2026
Officer purchased ~$2.9K of CMPX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deerfield Management Company, L.P. no longer reported CMPX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Montanova Capital, LLC disclosed a reduced position in CMPX for Q2 2026SourceInsider trade · Traded Apr 29, 2026 · Filed Apr 30, 2026
Officer purchased ~$47K of CMPX shares in the open marketSourceInsider trade · Traded Apr 29, 2026 · Filed Apr 30, 2026
Officer purchased ~$28K of CMPX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. disclosed a new position in CMPX for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Montanova Capital, LLC disclosed an increased position in CMPX for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Montanova Capital, LLC disclosed a new position in CMPX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed a reduced position in CMPX for Q2 2025SourceInsider trade · Traded May 27, 2025 · Filed May 27, 2025
CEO purchased ~$21K of CMPX shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 11, 2025
Director sold ~$5.68M of CMPX shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 11, 2025
Director sold ~$5.68M of CMPX shares in the open marketSourceInsider trade · Traded Apr 7, 2025 · Filed Apr 8, 2025
Officer purchased ~$31K of CMPX shares in the open marketSourceInsider trade · Traded Apr 7, 2025 · Filed Apr 8, 2025
Officer purchased ~$28K of CMPX shares in the open marketSource